Possible repurposing of seasonal influenza vaccine for prevention of Zika virus infection

F1000Research

Volumn 5, Issue , 2016, Pages

  Veljkovic, Veljko ^a   Paessler, Slobodan ^b,c  

^a Biomed Protection   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

^c Galveston National Laboratory   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN E; INFLUENZA VACCINE; INFLUENZA VIRUS HEMAGGLUTININ; INFLUENZA VIRUS HEMAGGLUTININ SUBUNIT 1; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN; VIRUS GLYCOPROTEIN;

AFRICA; ASIA; CENTRAL AMERICA; COMPUTER ANALYSIS; DRUG REPOSITIONING; INFECTION PREVENTION; INFLUENZA A VIRUS (H1N1); NONHUMAN; NOTE; SOUTH AMERICA; SPECTROSCOPY; VIRUS ISOLATION; ZIKA FEVER; ZIKA VIRUS;

EID: 84978532255     PISSN: 20461402     EISSN: 1759796X     Source Type: Journal    
DOI: 10.12688/f1000research.8102.2     Document Type: Note

References (12)

1. Veljković V Metlas R: Identification of nanopeptide from HTLV-III, ARV-2 and LAVBRU envelope gp120 determining binding to T4 cell surface protein. Cancer Biochem Biophys. 1988;10(2):91-106. 2855309
2. Veljkovic V Niman HL Glisic S: Identification of hemagglutinin structural domain and polymorphisms which may modulate swine H1N1 interactions with human receptor. BMC Struct Biol. 2009;9:62. 19785758 10.1186/1472-6807-9-62 2760557
3. Veljkovic V Glisic S Muller CP: In silico analysis suggests interaction between Ebola virus and the extracellular matrix. Front Microbiol. 2015;6:135. 25745423 10.3389/fmicb.2015.00135 4333865
4. Veljković V Cosić I Dimitrijević B: Is it possible to analyze DNA and protein sequences by the methods of digital signal processing? IEEE Trans Biomed Eng. 1985;32(5):337-341. 2581884 10.1109/TBME.1985.325549
5. Veljkovic N Glisic S Prljic J: Discovery of new therapeutic targets by the informational spectrum method. Curr Protein Pept Sci. 2008;9(5):493-506. 18855700 10.2174/138920308785915245
6. Veljkovic V Veljkovic N Muller CP: Characterization of conserved properties of hemagglutinin of H5N1 and human influenza viruses: possible consequences for therapy and infection control. BMC Struct Biol. 2009;9:21. 19351406 10.1186/1472-6807-9-21 2679750
7. Perovic VR Muller CP Niman HL: Novel phylogenetic algorithm to monitor human tropism in Egyptian H5N1-HPAIV reveals evolution toward efficient human-to-human transmission. PLoS One. 2013;8(4):e61572. 23658611 10.1371/journal.pone.0061572 3637272
8. Schmier S Mostafa A Haarmann T: In Silico Prediction and Experimental Confirmation of HA Residues Conferring Enhanced Human Receptor Specificity of H5N1 Influenza A Viruses. Sci Rep. 2015;5: 11434. 26091504 10.1038/srep11434 4473683
9. Veljkovic V Paessler S Glisic S: Evolution of 2014/15 H3N2 Influenza Viruses Circulating in US: Consequences for Vaccine Effectiveness and Possible New Pandemic. Front Microbiol. 2015;6:1456. 26733989 10.3389/fmicb.2015.01456 4686605
10. Veljkovic V Glisic S Veljkovic N: Influenza vaccine as prevention for cardiovascular diseases: possible molecular mechanism. Vaccine. 2014;32(48):6569-6575. 25045818 10.1016/j.vaccine.2014.07.007
11. Veljkovic V Paessler S: Dataset 1 in: Possible repurposing of seasonal influenza vaccine for prevention of Zika virus infection. F1000Research. 2016. Data Source
12. Veljkovic V Paessler S: Dataset 2 in: Possible repurposing of seasonal influenza vaccine for prevention of Zika virus infection. F1000Research. 2016. Data Source